Blog

Visit AHFS at MLA: Mosaic 16 in Toronto!

If you’re attending MLA: Mosaic 16, May 13th – 18th in Toronto, visit the ASHP booth, #726, and get an exclusive preview of AHFS Clinical Drug Information, the next big thing for easy access to real-time drug information and updates.

Sign up for more information about AHFS Clinical Drug Information and other ASHP products for institutions, and register for a chance to win a Fitbit Charge HR!

fitbit

AHFS Drug Information/Essentials Update – May 2016

The May update to the AHFS Drug Information/Essentials database was published today. Highlights from this month’s update include:

New AHFS/Essentials Monographs

  • Ganciclovir (Zirgan®)
    • The ophthalmic gel is indicated for the topical treatment of acute herpetic keratitis in patients with dendritic ulcers

FDA MedWatch Alerts

  • Metformin
    • Revised warnings in reduced kidney function
  • Fluconazole
    • FDA is evaluating the results of a Danish study that concluded there is a possible increased risk of miscarriage with the use of oral fluconazole for yeast infections
  • Aripiprazole
    • Warning regarding compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex have been reported
  • Ticagrelor and Vortioxetine
    • Brand name change for vortioxetine (Brintellix) due to name confusion with ticagrelor (Brilinta)

AHFS Patient Medication Information Update – April 2016

The April update to the AHFS Patient Medication Information (PMI) database has been published. Highlights of this month’s update include:

New AHFS PMI Monographs

  • Buprenorphine Buccal (Belbuca®), indicated for severe chronic pain
  • Emtricitabine/Rilpivirine/Tenofovir (Complera®), indicated for HIV infection
  • Lesinurad (Zurampic®), indicated for hyperuricemia in people with gout
  • Posaconazole Injection (Noxafil®), indicated for prevention of fungal infections in people with weakened ability to fight infections

FDA MedWatch Alerts

  • New safety warnings for opioids
  • Risk of heart failure for alogliptin and saxagliptin
  • New safety warning for metformin in patients with reduced kidney function
1 10 11 12 13